ASTRAZENECA PLC (AZN)
Clinical trial NCT06723795 updates: 1. completion date: 2027-08-01 → 2027-03-01 2. primary completion date: 2027-03-01 → 2026-07-25 3. allocation: RANDOMIZED → NON_RANDOMIZED 4. intervention model: PARALLEL → SEQUENTIAL 5. masking: DOUBLE → SINGLE
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical